Business - Briefly   

Biovel Life in pact with Dowpharma

BANGALORE: Biovel Life Sciences Pvt. Ltd, the Bangalore-based biotechnology enterprise, has signed a licensing agreement with the U.S.-based Dowpharma to produce its proprietary human growth hormone (HGH) product. The HGH market worldwide is now close to $3 billion, the products so far imported into India, Biovel’s Chairman and Managing Director, P. Sudhakera Naidu, told reporters here on Thursday.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Oriental Insurance net up 75 p.c.
Sanyo-BPL repositions strategy to beat competition
Insurance cover for HIV patients from Star Health
Wipro acquires Singapore firm for $256 m
Rupee edges down
MRPL to supply petro products to Mauritius
Sensex hits 15000-mark
Wipro acquires Singapore firm for $256 m
Kaashyap Tech rejigs growth strategy
Tata Indicom launches ‘Parsec’
Gillette slashes price of ‘Vector Plus’ in TN
Metso Paper to supply equipment to Subburaj
Biovel Life in pact with Dowpharma
Inflation rate looks up
HDIL IPO price fixed at Rs. 500
MMTC invites bids for pig iron exports
ICICI Bank reduces floating rate

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu